Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy -- Ignore unavailable to you. Want to Upgrade?

To: Todd A. Sinelli who wrote (102)	3/5/1998 4:54:00 PM
From: deadstrait	Read Replies (1) \| Respond to of 184

On Feb 12, Sangstat announced that they were responding to the FDA regarding their Minor Deficiency Letter. They stated that response would take two to three weeks. It is my understanding that the response has been made regarding both Thymo and Sang35. Now it is up to the FDA. The ball is in their court, so to speak. My feeling is that when the approval is received, (note: I said "when" not "if"),it will be a wonderful time in SANG land. Of course, these are my opinions. But, I feel they are qualified based on facts found during proper research. later dead .